SELLAS Life Sciences Income Statement (2010-2026) | SLS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Shares Outstanding (Entity) (Quarter)
Revenue & cost
Revenue (Quarter)	1.90M			1.00M
Gross Profit (Quarter)	1.80M			0.90M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	3.46M	4.54M	3.39M	4.61M	5.53M	4.28M	5.85M	7.17M	5.92M	5.81M	5.10M	5.11M	5.19M	4.36M	4.44M	3.21M	3.87M	4.22M	4.73M	5.13M
Selling, General & Administrative (Quarter)	2.80M	2.44M	2.53M	3.02M	3.09M	2.86M	3.60M	4.11M	3.13M	3.55M	3.08M	4.53M	2.44M	2.97M	2.48M	2.86M	3.00M	2.87M	3.52M	4.12M
Other Operating Expenses (Quarter)	-0.16M	-0.11M	5.70M	-0.01M	0.21M	0.12M		0.18M
Operating Expenses (Quarter)	6.35M	6.98M	11.62M	17.73M	8.62M	7.15M	9.45M	11.28M	9.05M	9.36M	8.18M	9.64M	7.62M	7.33M	6.92M	6.06M	6.87M	7.08M	8.26M	9.25M
Operating Income (Quarter)	-4.45M	-6.98M	-11.62M	-16.73M	-8.62M	-7.15M	-9.45M	-11.28M	-9.05M	-9.36M	-8.18M	-9.64M	-7.62M	-7.33M	-6.92M	-6.06M	-6.87M	-7.08M	-8.26M	-9.25M
EBIT (Quarter)	-4.45M	-6.98M	-11.62M	-16.73M	-8.62M	-7.15M	-9.45M	-11.28M	-9.05M	-9.36M	-8.18M	-9.64M	-7.62M	-7.33M	-6.92M	-6.06M	-6.87M	-7.08M	-8.26M	-9.25M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)					0.21M	0.12M	0.33M	0.18M	0.21M	0.09M	0.04M	0.08M	0.15M	0.22M	0.18M	0.25M	0.27M	0.29M	0.60M	0.84M
Net income details
EBT (Quarter)	-4.55M	-7.08M	-11.72M	-16.84M	-8.72M	-7.25M	-9.65M	-11.38M	-9.15M	-9.46M	-8.28M	-9.74M	-7.72M	-7.43M	-7.02M	-6.26M	-8.93M	-7.28M	-8.36M	-15.05M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-4.61M	-7.08M	-6.60M	-16.74M	-8.41M	-7.02M	-9.12M	-11.10M	-8.84M	-9.27M	-8.14M	-9.57M	-7.47M	-7.11M	-6.74M	-5.81M	-6.60M	-6.79M	-7.70M	-8.40M
Income from Continuing Operations (Quarter)	-4.55M	-7.08M	-11.72M	-16.84M	-8.72M	-7.25M	-9.65M	-11.38M	-9.15M	-9.46M	-8.28M	-9.74M	-7.72M	-7.43M	-7.02M	-6.26M	-8.93M	-7.28M	-8.36M	-15.05M
Consolidated Net Income (Quarter)	-4.55M	-7.08M	-11.72M	-16.84M	-8.72M	-7.25M	-9.65M	-11.38M	-9.15M	-9.46M	-8.28M	-9.74M	-7.72M	-7.43M	-7.02M	-6.26M	-8.93M	-7.28M	-8.36M	-15.05M
Income towards Parent Company (Quarter)	-4.55M	-7.08M	-11.72M	-16.84M	-8.72M	-7.25M	-9.65M	-11.38M	-9.15M	-9.46M	-8.28M	-9.74M	-7.72M	-7.43M	-7.02M	-6.26M	-8.93M	-7.28M	-8.36M	-15.05M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-4.61M	-7.08M	-6.60M	-16.84M	-8.72M	-7.25M	-9.65M	-11.38M	-9.15M	-9.46M	-8.28M	-9.74M	-7.72M	-7.43M	-7.02M	-6.26M	-8.93M	-7.28M	-8.36M	-15.05M
Additional items
EPS (Basic) (Quarter)	-0.30	-0.45	-0.43	-1.06	-0.43	-0.35	-0.50	-0.48	-0.32	-0.33	-0.30	-0.22	-0.13	-0.11	-0.11	-0.07	-0.09	-0.07	-0.08	-0.09
EPS (Diluted) (Quarter)	-0.30	-0.45	-0.43	-1.06	-0.43	-0.35	-0.50	-0.48	-0.32	-0.33	-0.30	-0.22	-0.13	-0.11	-0.11	-0.07	-0.09	-0.07	-0.08	-0.09
Shares Outstanding (Quarter)	15.27M	15.87M	15.48M	15.90M	20.29M	20.56M	19.40M	23.55M	28.35M	28.36M	27.78M	44.81M	57.63M	68.25M	61.20M	87.76M	98.56M	108.40M	109.05M	172.48M
Shares Outstanding (Diluted) (Quarter)	15.27M	15.87M	15.48M	15.90M	20.29M	20.56M	19.40M	23.55M	28.35M	28.36M	27.78M	44.81M	57.63M	68.25M	61.20M	87.76M	98.56M	108.40M	109.05M	172.48M
EBITDA (Quarter)	-4.45M	-6.98M	-11.62M	-16.73M	-8.62M	-7.15M	-9.45M	-11.28M	-9.05M	-9.36M	-8.18M	-9.64M	-7.62M	-7.33M	-6.92M	-6.06M	-6.87M	-7.08M	-8.26M	-9.25M
Interest Expenses (Quarter)	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.20M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.20M	2.06M	0.20M	0.10M	5.80M
Tax Rate (Quarter)

Research Tools

Developers

SELLAS Life Sciences Income Statement (2010-2026) | SLS

Research Tools

Developers

SELLAS Life Sciences Income Statement (2010-2026) | SLS

Create an account

Sign In

Reset Password